On Wednesday, American Tower Corp (NYSE:AMT)’s shares inclined 0.92% to $94.12.
American Tower Corp (AMT) declared that its board of directors has declared its quarterly cash distribution of $0.44 per share on shares of the Company’s common stock. The distribution is payable on July 16, 2015 to such stockholders of record at the close of business on June 17, 2015.
American Tower Corporation is a real estate investment trust. It invests in the real estate markets across the globe. The firm engages in leasing of space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data and data providers, government agencies and municipalities and tenants in a number of other industries. American Tower Corporation was founded in 1995 and is headquartered in Boston, Massachusetts.
Splunk Inc (NASDAQ:SPLK)’s shares gained 1.36% to $71.54.
Splunk Inc (SPLK) declared the Corvil Add-on for Splunk that streams network data analytics to Splunk® Enterprise. The Corvil Add-on for Splunk allows customers to route valuable network data analytics into Splunk, making it accessible for real-time analysis and data mining over longer timescales. Download the Corvil Add-on for Splunk now.
With the Corvil Add-on for Splunk software, customers will gain deeper insight into their network data. By combining the richest source of business and application insights from the network, together with machine data harvested from the application servers, Corvil customers can see the full picture of end-to-end transactional performance. Corvil customers can track true user experience with Splunk Enterprise and correlate with network and application server events.
Splunk, Inc. provides software products that enable organizations to gain real-time operational intelligence in the United States and internationally. The company’s products enable users to collect, index, search, explore, monitor, and analyze data regardless of format or source users. It offers Splunk Enterprise, a machine data engine with collection, indexing, search, reporting analysis, alerting, monitoring, and data administration capabilities; and Splunk Cloud service.
At the end of Wednesday’s trade, KKR & Co. L.P. (NYSE:KKR)‘s shares dipped -0.52% to $22.79.
Bayer AG has reached a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd., a company which is backed by funds sponsored by leading global investment firm KKR and the Panasonic Corporation. The total consideration for the transaction is EUR 1,022 million. The sale will comprise the leading Contour™ portfolio of blood glucose monitoring meters and strips, in addition to other products such as Breeze™2, Elite™ and Microlet™ lancing devices. Closing of the transaction is subject to customary conditions, counting relevant antitrust clearance, and is predictable to occur in the first quarter of 2016.
Johannes Huth , Member and Head of KKR Europe, Africa and Middle East , and Hiro Hirano , Member and CEO of KKR Japan, said, “We are happy that Bayer Diabetes Care chose Panasonic Healthcare and KKR as the trusted partners for bringing the business to its next stage of development. This is another milestone in KKR’s track record of partnering with leading German and Japanese corporates and in growing top health care companies. Together, we will leverage our experience and network to create a global diabetes care solutions powerhouse in an effort to make this a transformational transaction for the diabetes care industry.”
Bayer’s Diabetes Care business is a technological leader in blood glucose monitoring systems, lancing devices and diabetes administration software. The business accounted for EUR 909 million in sales in 2014, with Contour™ being the principal product portfolio. The Contour™ portfolio comprises Contour™ Next, Contour™ Plus, Contour™ and Contour™ TS and is designed to meet the needs of all patients regardless of type of diabetes, stage of disease, or testing frequency. Other products comprise Breeze™2, Brio™, Entrust™, Elite™ and Microlet™ lancing devices.
KKR & Co. L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, administration buyouts, credit special situations, growth equity, mature, mezzanine, distressed, and middle market investments.
CBL & Associates Properties, Inc. (NYSE:CBL), ended its Wednesday’s trading session with 0.59% gain, and closed at $17.04.
CBL & Associates Properties, Inc. (CBL) declared that it closed on the sale of Eastgate Crossing, a 175,000-square-foot community center located in Cincinnati, OH. The gross sales price of $22.8 million comprises $1.7 million of future earn-out payments and the assumption of a $14.6 million loan secured by the property. The center was attained by a joint venture of Inland Real Estate Corporation.
CBL & Associates Properties, Inc. is a public real estate investment trust. It engages in acquisition, development, and administration of properties. The fund invests in the real estate markets of United States. Its portfolio comprises of enclosed malls and open-air centers. CBL & Associates Properties is based in Oak Brook, Illinois. CBL & Associates Properties was founded in 1978 and is based in Chattanooga, Tennessee with additional offices in Waltham, Massachusetts; Chesterfield, Missouri; and Irving, Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
